Alentis Therapeutics

Drug Discovery · Allschwil, Switzerland · Founded 2019 · Privately Held (backing)

Operator of a clinical-stage biopharmaceutical company intended to offer various treatments for cancer and fibrotic diseases. Alentis Therapeutics is based in Allschwil, Switzerland and was founded in 2019. It has raised $362 million across 2 recorded rounds; the latest was an $181 million Series D in Nov 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$362.5M
Last round
Later Stage VC (Series D)
Nov 2024
How much has Alentis Therapeutics raised?
$362.5Macross 2 recorded rounds · Apr 2023 – Nov 2024

Most recently, Alentis Therapeutics raised $181.4M in its Later Stage VC (Series D) (Nov 2024).

Free account
More of Alentis Therapeutics with a free account
  • ·The complete investor list: 21 names
  • ·Watch Alentis Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Alentis Therapeutics round by round

2 rounds
Nov 2024Later Stage VC (Series D)$181.4M▮
+ 1 more investors · free account
Apr 2023Later Stage VC (Series C)$101.7M▮
+ 1 more investors · free account

How much has Alentis Therapeutics raised?

Alentis Therapeutics has raised $362 million in total; 2 of its rounds are on record. The largest on record was an $181 million Series D in Nov 2024.

Alentis Therapeutics investors

21 investors are on record for Alentis Therapeutics, including Bpifrance, RA Capital Management, High-Tech Gründerfonds and OrbiMed. By type, the record holds 5 venture capital firms and 1 family office. The Series D in Nov 2024 drew 12 investors.

For fundraisers
Raising for a company like Alentis Therapeutics?

21 investors have backed Alentis Therapeutics — start your target list with the firms already writing checks in drug discovery.

See all 21 investors →

Frequently asked about Alentis Therapeutics

How much has Alentis Therapeutics raised?
Alentis Therapeutics has raised $362.5M in total across 2 recorded funding rounds.
When was Alentis Therapeutics's last funding round?
Alentis Therapeutics's most recent recorded round was Later Stage VC (Series D) in Nov 2024, raising $181.4M.